microRNA-21 Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury and Alleviates Blood-Brain Barrier Disruption in Rats via the MAPK Signaling Pathway
The mechanism contributing to blood-brain barrier (BBB) disruption, involved in poststroke edema and hemorrhagic transformation, is important but elusive. We investigated microRNA-21 (miR-21)-mediated mechanism in the disruption of BBB following cerebral ischemia-reperfusion (I/R) injury. Rats with cerebral I/R injury were prepared after middle cerebral artery occlusion and subsequent reperfusion. The underlying regulatory mechanisms of miR-382 were investigated with treatment of miR-382 mimics, miR-382 inhibitors, or SB203580 (an inhibitor of the MAPK signaling pathway) prior to I/R modeling. Compared with sham-operated rats, rats following I/R showed increased Longa’s scores, ischemic hemisphere volume, cerebral infarct volume, EB content in brain tissues, enhanced levels of p38, iNOS, and MMP-9. The ectopic expression of miR-21 by mimics and MAPK signaling inhibition by SB203580 reduced Longa’s scores, ischemic hemisphere volume, cerebral infarct volume, EB content in brain tissues, decreased levels of p38, MAP2K3, iNOS, and MMP-9. The luciferase activity determination showed miR-21 bound to MAP2K3 in its 3′UTR. miR-21 downregulation mediated by inhibitors appeared to yield an opposed trend. We also found that MAPK signaling inhibition by SB203580 could rescue rats with treatment of miR-382 inhibitors. The study highlights the neuroprotective role of MiR-21 during cerebral I/R injury and its preventive effect against BBB disruption by blocking the MAPK signaling pathway via targeted inhibition of MAP2K3, potentially opening a novel therapeutic avenue for the treatment of cerebral ischemia.
KeywordsmicroRNA-21 MAPK signaling pathway Cerebral ischemia-reperfusion injury Blood-brain barrier Neuronal remodeling
The authors thank the reviewers for their helpful comments.
Compliance with Ethical Standards
The experimental protocols of the present study were approved by the Animal Care Committee at Xianyang hospital, Yan’an University.
Conflict of Interest
The authors declare that they have no conflicts of interest.
- Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, Sun L, Ma B, Ding J, Vancraenenbroeck R, Lobbestael E, Baekelandt V, Taymans JM, He P, Troncoso JC, Shen Y, Cai H (2013) MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22(3):608–620. https://doi.org/10.1093/hmg/dds470 CrossRefPubMedGoogle Scholar
- Chumboatong W, Thummayot S, Govitrapong P, Tocharus C, Jittiwat J, Tocharus J (2017) Neuroprotection of agomelatine against cerebral ischemia/reperfusion injury through an antiapoptotic pathway in rat. Neurochem Int 102:114–122. https://doi.org/10.1016/j.neuint.2016.12.011 CrossRefPubMedGoogle Scholar
- Deng X, Zhong Y, Gu L, Shen W, Guo J (2013) MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia. Brain Res Bull 94:56–62. https://doi.org/10.1016/j.brainresbull.2013.02.007 CrossRefPubMedGoogle Scholar
- Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, Choi EJ, Kim G, Shin SH, Gwak HS, Kim SK, Hong EK, Lee GK, Choi KH, Kim JH, Yoo H, Park JB, Lee SH (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30(21):2433–2442. https://doi.org/10.1038/onc.2010.620 CrossRefPubMedGoogle Scholar
- Lim AK, Nikolic-Paterson DJ, Ma FY, Ozols E, Thomas MC, Flavell RA, Davis RJ, Tesch GH (2009) Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia 52(2):347–358. https://doi.org/10.1007/s00125-008-1215-5 CrossRefPubMedGoogle Scholar
- Liu X, Li Z, Song Y, Wang R, Han L, Wang Q, Jiang K, Kang C, Zhang Q (2016) AURKA induces EMT by regulating histone modification through Wnt/beta-catenin and PI3K/Akt signaling pathway in gastric cancer. Oncotarget 7(22):33152–33164. https://doi.org/10.18632/oncotarget.8888 PubMedPubMedCentralCrossRefGoogle Scholar
- Ma N, Bai J, Zhang W, Luo H, Zhang X, Liu D, Qiao C (2016) Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA21 expression, Akt and the Bcl2/Bax pathway. Mol Med Rep 14(5):4216–4222. https://doi.org/10.3892/mmr.2016.5773 CrossRefPubMedPubMedCentralGoogle Scholar
- Qiao S, Olson JM, Paterson M, Yan Y, Zaja I, Liu Y, Riess ML, Kersten JR, Liang M, Warltier DC, Bosnjak ZJ, Ge ZD (2015) MicroRNA-21 mediates Isoflurane-induced Cardioprotection against ischemia-reperfusion injury via Akt/nitric oxide synthase/mitochondrial permeability transition pore pathway. Anesthesiology 123(4):786–798. https://doi.org/10.1097/ALN.0000000000000807 CrossRefPubMedPubMedCentralGoogle Scholar
- Tuo YL, Li XM, Luo J (2015) Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. European Rev Medical Pharmacological Sci 19(18):3403–3411Google Scholar
- Zhang JF, Shi LL, Zhang L, Zhao ZH, Liang F, Xu X, Zhao LY, Yang PB, Zhang JS, Tian YF (2016) MicroRNA-25 negatively regulates cerebral ischemia/reperfusion injury-induced cell apoptosis through Fas/FasL pathway. J Molecular Neuroscience : MN 58(4):507–516. https://doi.org/10.1007/s12031-016-0712-0 CrossRefGoogle Scholar